Lexapro, Escitalopram Newswire

Lexapro, Escitalopram Newswire

Comprehensive Real-Time News Feed for Lexapro, Escitalopram (generic).

Results 1 - 20 of 72 in Lexapro, Escitalopram (generic)

  1. New insights into the pharmacogenomics of antidepressant response...Read the original story

    Tuesday Nov 21 | The Pharmacogenomics Journal

    Genome-wide association studies have generally failed to identify polymorphisms associated with antidepressant response. Possible reasons include limited coverage of genetic variants that this study tried to address by exome genotyping and dense imputation.

    Comment?

  2. PCORI Board approves $57 million to support new patient-centered CER studiesRead the original story w/Photo

    Monday Nov 20 | EurekAlert!

    The Patient-Centered Outcomes Research Institute Board of Governors today approved $57 million to fund 14 new comparative clinical effectiveness research studies. The funds will support studies of a range of conditions and problems that impose high burdens on patients, caregivers and the healthcare system.

    Comment?

  3. Lexapro vs. Wellbutrin: Differences between Side Effects and UsesRead the original story w/Photo

    Thursday Nov 2 | MedicineNet

    John P. Cunha, DO, is a U.S. board-certified Emergency Medicine Physician. Dr. Cunha's educational background includes a BS in Biology from Rutgers, the State University of New Jersey, and a DO from the Kansas City University of Medicine and Biosciences in Kansas City, MO.

    Comment?

  4. The power of thought: New study finds that what depression patients...Read the original story w/Photo

    Thursday Nov 2 | NewsTarget.com

    The efficacy of selective serotonin reuptake inhibitors in the treatment of depression has long been questioned within the scientific community due to varying study results. However, recent research published in the EBioMedicine journal has demonstrated that the drug's efficacy may also be dependent on a patient's perceptions about the treatment.

    Comment?

  5. Trial compares long term-effects of psychotherapy and antidepressants on depression symptomsRead the original story w/Photo

    Oct 24, 2017 | Medical News

    In the current issue of Psychotherapy and Psychosomatics there are data about the long term-effects of a form of psychotherapy in depression compared to medication. Compared to episodic depression, only a limited number of follow-up studies for chronic depression exist despite its poor long-term course.

    Comment?

  6. Researchers confirm transcranial stimulation effects and determine a key mechanismRead the original story w/Photo

    Oct 13, 2017 | PhysOrg Weblog

    HRL Laboratories researchers have determined how non-invasive transcranial direct current stimulation could increase performance of associative learning. The researchers found that when applied to the prefrontal cortex, tDCS affects a wide portion of the brain, causing changes in functional connectivity between different brain areas that increased learning speed in macaques.

    Comment?

  7. Do Antidepressants Work Because People Believe They Do?Read the original story w/Photo

    Oct 9, 2017 | News Max

    People who take antidepressants may report they effectively relieve symptoms merely because they expect them to do so. That's the intriguing finding of Swedish researchers who found that believing in the value of such medications influences their benefits.

    Comment?

  8. Belief that Depression Meds Will Help May Make It SoRead the original story w/Photo

    Oct 4, 2017 | PsychCentral

    Experts believe the findings suggest that the way in which the treatment is described to the patient can be as important as the treatment itself. Moreover, the discovery may help to explain why selective serotonin reuptake inhibitors work for some individuals but not for others.

    Comment?

  9. Patients' expectations influence the effectiveness of SSRI antidepressantsRead the original story w/Photo

    Oct 2, 2017 | EurekAlert!

    Selective serotonin reuptake inhibitors are commonly prescribed for depression and anxiety but their superiority over placebo has been questioned, generating considerable debate among researchers and clinicians. In a new study, Uppsala University researchers show that the way in which the treatment is described to the patient can be as important as the treatment itself.

    Comment?

  10. Patients' expectations influence effectiveness of SSRI antidepressantsRead the original story w/Photo

    Oct 3, 2017 | PhysOrg Weblog

    Selective serotonin reuptake inhibitors are commonly prescribed for depression and anxiety but their superiority over placebo has been questioned, generating considerable debate among researchers and clinicians. In a new study, Uppsala University researchers show that the way in which the treatment is described to the patient can be as important as the treatment itself.

    Comment?

  11. Patients expectations influence the effectiveness of SSRI antidepressantsRead the original story

    Oct 2, 2017 | PressReleasePoint

    Selective serotonin reuptake inhibitors are commonly prescribed for depression and anxiety but their superiority over placebo has been questioned, generating considerable debate among researchers and clinicians. In a new study, Uppsala University researchers show that the way in which the treatment is described to the patient can be as important as the treatment itself.

    Comment?

  12. Cross-trial prediction of treatment outcome in depression: a machine learning approachRead the original story

    Oct 1, 2017 | CiteULike

    The Lancet Psychiatry , Vol. 3, No. 3. , pp. 243-250, doi:10.1016/s2215-0366 00471-x Background Antidepressant treatment efficacy is low, but might be improved by matching patients to interventions.

    Comment?

  13. Preventing depression in people who have never had itRead the original story w/Photo

    Sep 29, 2017 | Jewish World Review

    For years, physicians have prescribed antidepressants to treat people grappling with depression. Some people can benefit from taking these medications during an acute episode.

    Comment?

  14. Antidepressant as preventive?If you were at risk for developing...Read the original story w/Photo

    Sep 24, 2017 | Journal Gazette

    For years, physicians have prescribed antidepressants to treat people grappling with depression.

    Comment?

  15. Preventing depression in people who have never had itRead the original story w/Photo

    Sep 20, 2017 | Stuff.co.nz

    For years, physicians have prescribed antidepressants to treat people grappling with depression. Some people can benefit from taking these medications during an acute episode.

    Comment?

  16. Baycrest launches study combining music and brain stimulation to improve memoryRead the original story w/Photo

    Sep 18, 2017 | PhysOrg Weblog

    Baycrest will embark on the first study combining music therapy with brain stimulation to improve memory among patients with Mild Cognitive Impairment . This study could pave the way to developing an affordable and easy-to-use treatment for MCI patients, who face a higher risk of developing Alzheimer's disease.

    Comment?

  17. Drugs Better than Transcranial Stimulation (tDCS) for DepressionRead the original story w/Photo

    Sep 1, 2017 | PsychCentral

    A new study from Brazil compares the benefit of medicinal therapy against low-intensity electrical brain stimulation for relief of depression . Specifically, investigators attempted to determine if transcranial direct-current stimulation is a comparable alternative to treatment with antidepressant drugs.

    Comment?

  18. Study finds transcranial direct-current stimulation to be less effective than anti-depressantsRead the original story w/Photo

    Aug 31, 2017 | Medical News

    A new study questions the efficacy of treatments for depression based on stimulating brain areas with low-intensity electric current. The technique, known as transcranial direct-current stimulation , was considered a promising alternative to treatment with antidepressant drugs.

    Comment?

  19. Drugs found to be more effective against depression than electric currentRead the original story w/Photo

    Aug 30, 2017 | EurekAlert!

    Researchers concluded that medicinal therapy was more than twice as effective as low-intensity brain stimulation, according to a study published in the New England Journal of Medicine IMAGE: Researchers concluded that medicinal therapy was more than twice as effective as low-intensity brain stimulation, according to a study published in the New England Journal of Medicine . view A new study questions the efficacy of treatments for depression based on stimulating brain areas with low-intensity electric current.

    Comment?

  20. Axsome Therapeutics Sweetens The Deal For InvestorsRead the original story w/Photo

    Aug 29, 2017 | Seeking Alpha

    There are a lot of competing drugs in the space which require review to predict the fate of AXS-05 in this indication. Axsome Therapeutics is a biopharmaceutical company with multiple phase 3 trials nearing interim data readouts, a market cap of approximately $112 million and cash anticipated to last until 2019.

    Comment?